CLINICAL_TRIALS
trial_result
· 2012-11-14
Clinical Trial Update: Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial [Phase 1]
Summary
Phase 1 trial update showing completion of the RIPT study evaluating Ranibizumab for idiopathic parafoveal telangiectasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Telangiectasia | Phase 1 | Status: COMPLETED